Maebashi Red Cross Hospital

Maebashi, Gunma 371-0811

0 studies enrolling now · 2 studies all time

What they study most

Acute Non-cardioembolic Ischemic Stroke, Crohn's Disease, High-risk Transient Ischemic Attack, Prevention of Ischemic Stroke

Studies at this site

• A Study to Test Asundexian for Preventing a Stroke Caused by a Clot in Participants After an Acute Ischemic Stroke or After a High-risk Transient Ischemic Attack, a So-called Mini Stroke — Completed
• A Study of Mirikizumab (LY3074828) in Participants With Crohn's Disease — Completed